|Mr. Roger John Dumoulin-White P.Eng. (Electrical)||Chairman, Pres & Chief Exec. Officer||313.7k||N/A||N/A|
|Ms. Kristina Hachey||Chief Financial Officer||133.33k||N/A||N/A|
|Dr. Arkady Mandel M.D., Ph.D., DSc.||Chief Scientific Officer||142.08k||N/A||N/A|
|Mr. David Smith||Director of Sales||N/A||N/A||N/A|
|Ms. Crystel Figaro||Director of Marketing||N/A||N/A||N/A|
Theralase Technologies Inc. designs, develops, manufactures, and markets super-pulsed cold laser technology for a range of human, companion animal, and equine applications. The company operates in two divisions, Therapeutic Laser Technology and Photo Dynamic Therapy. It engages in the production, marketing, and distribution of TLC-1000 and TLC-2000 laser technology for the treatment of nerve, muscle, tendon, ligament, joint, and wound conditions through the elimination of pain, reduction of inflammation, and acceleration of tissue healing. The company is also involved in the research, development, and commercialization of the patented and patent pending TLC-3000 medical laser and photo dynamic compound anti-cancer technology through preclinical research, clinical trials, and technology development to destroy cancers for oncological applications, as well as to destroy bacteria for human, animal, and sterilization applications. In addition, it operates a full service medical rehabilitation clinic in Toronto, Ontario for training and education of health-care practitioners. The company sells its products to licensed healthcare practitioners in Canada and the United States. Theralase Technologies Inc. has strategic partnerships with University Health Network, Ontario Centers of Excellence for Photonics, National Research Council of Canada, Virginia Tech, The Scripps Research Institute, Mayo Clinic, University of Buffalo, and JSS Medical Research, as well as clinical research agreements with Princess Margaret Cancer Centre and University Health Network. The company was founded in 1994 and is based in Toronto, Canada.
Theralase Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.